loadpatents
name:-0.040441036224365
name:-0.028012037277222
name:-0.0025160312652588
Wallace; Eli Patent Filings

Wallace; Eli

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wallace; Eli.The latest application filed is for "quinazoline analogs as receptor tyrosine kinase inhibitors".

Company Profile
2.22.34
  • Wallace; Eli - Richardson TX
  • Wallace; Eli - Lyons CO US
  • Wallace; Eli - Boulder CO US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Quinazoline analogs as receptor tyrosine kinase inhibitors
Grant 11,174,273 - Wallace , et al. November 16, 2
2021-11-16
Quinazoline Analogs As Receptor Tyrosine Kinase Inhibitors
App 20210284656 - Wallace; Eli ;   et al.
2021-09-16
Quinazoline Analogs As Receptor Tyrosine Kinase Inhibitors
App 20210269455 - Wallace; Eli ;   et al.
2021-09-02
Quinazoline Analogs As Receptor Tyrosine Kinase Inhibitors
App 20190161500 - Wallace; Eli ;   et al.
2019-05-30
Quinazoline analogs as receptor tyrosine kinase inhibitors
Grant 10,221,194 - Wallace , et al.
2019-03-05
Quinazoline Analogs As Receptor Tyrosine Kinase Inhibitors
App 20170260202 - Wallace; Eli ;   et al.
2017-09-14
Quinazoline analogs as receptor tyrosine kinase inhibitors
Grant 9,676,791 - Wallace , et al. June 13, 2
2017-06-13
Serine/threonine kinase inhibitors
Grant 9,133,187 - Blake , et al. September 15, 2
2015-09-15
Serine/threonine Kinase Inhibitors
App 20130338140 - Blake; James F. ;   et al.
2013-12-19
Quinazoline Analogs As Receptor Tyrosine Kinase Inhibitors
App 20130245256 - Wallace; Eli ;   et al.
2013-09-19
Heterocyclic Inhibitors Of Mek And Methods Of Use Thereof
App 20130018075 - Marlow; Allison L. ;   et al.
2013-01-17
Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6- -dihydropyridine-3-carboxamide
Grant 8,299,076 - Marlow , et al. October 30, 2
2012-10-30
Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
App 20120263679 - Marlow; Allison L. ;   et al.
2012-10-18
Quinazoline analogs as receptor tyrosine kinase inhibitors
Grant 8,278,314 - Wallace , et al. October 2, 2
2012-10-02
Substituted pyridazines inhibitors of MEK
Grant 8,101,611 - Marlow , et al. January 24, 2
2012-01-24
Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
Grant 8,088,766 - Wallace , et al. January 3, 2
2012-01-03
Heterocyclic Inhibitors of MEK and Methods of Use Thereof
App 20110288092 - Marlow; Allison L. ;   et al.
2011-11-24
Heterocyclic Inhibitors Of Mek And Methods Of Use Thereof
App 20110183981 - Marlow; Allison L. ;   et al.
2011-07-28
Heterocyclic Inhibitors Of Mek And Methods Of Use Thereof
App 20110178136 - Marlow; Allison L. ;   et al.
2011-07-21
Quinazoline analogs as receptor tyrosine kinase inhibitors
Grant 7,777,032 - Wallace , et al. August 17, 2
2010-08-17
Bicyclic inhibitors of MEK and methods of use thereof
Grant 7,772,234 - Wallace , et al. August 10, 2
2010-08-10
Heterocyclic Inhibitors Of Mek And Methods Of Use Thereof
App 20100063053 - Marlow; Allison L. ;   et al.
2010-03-11
Quinazoline Analogs As Receptor Tyrosine Kinase Inhibitors
App 20090270621 - Wallace; Eli ;   et al.
2009-10-29
Heterocyclic inhibitors of MEK and methods of use thereof
Grant 7,598,383 - Marlow , et al. October 6, 2
2009-10-06
Quinazoline analogs as receptor tyrosine kinase inhibitors
Grant 7,585,975 - Wallace , et al. September 8, 2
2009-09-08
Heterocyclic Inhibitors Of Mek And Methods Of Use Thereof
App 20090215834 - Marlow; Allison L. ;   et al.
2009-08-27
Heterocyclic inhibitors of MEK and methods of use thereof
Grant 7,576,072 - Wallace , et al. August 18, 2
2009-08-18
Heterocyclic Inhibitors Of Mek And Methods Of Use
App 20090131435 - Marlow; Allison L. ;   et al.
2009-05-21
Heterocyclic inhibitors of MEK and methods of use thereof
Grant 7,517,994 - Marlow , et al. April 14, 2
2009-04-14
Quinazoline analogs as receptor tyrosine kinase inhibitors
Grant 7,501,427 - Wallace , et al. March 10, 2
2009-03-10
Quinazoline Analogs As Receptor Tyrosine Kinase Inhibitors
App 20090048279 - Wallace; Eli ;   et al.
2009-02-19
Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
Grant 7,488,823 - Wallace , et al. February 10, 2
2009-02-10
Bicyclic inhibitors of MEK and methods of use thereof
Grant 7,485,643 - Wallace , et al. February 3, 2
2009-02-03
Cyanoguanidines And Cyanoamidines As Erbb2 And Egfr Inhibitors
App 20090012290 - Wallace; Eli ;   et al.
2009-01-08
Quinazoline analogs as receptor tyrosine kinase inhibitors
Grant 7,452,895 - Wallace , et al. November 18, 2
2008-11-18
Quinazoline analogs as receptor Tyrosine Kinase inhibitors
App 20080194558 - Wallace; Eli ;   et al.
2008-08-14
Heterocyclic inhibitors of MEK and methods of use thereof
Grant 7,230,099 - Wallace , et al. June 12, 2
2007-06-12
Heterocyclic inhibitors of MEK and methods of use thereof
Grant 7,144,907 - Wallace , et al. December 5, 2
2006-12-05
Heterocyclic inhibitors of MEK and methods of use thereof
App 20060189808 - Wallace; Eli ;   et al.
2006-08-24
Heterocyclic inhibitors of MEK and methods of use thereof
App 20060189649 - Wallace; Eli ;   et al.
2006-08-24
Method of treating hyperproliferative disorders using heterocyclic inhibitors of MEK
App 20060189668 - Wallace; Eli ;   et al.
2006-08-24
Heterocyclic inhibitors of MEK and methods of use thereof
App 20050256123 - Marlow, Allison L. ;   et al.
2005-11-17
Heterocyclic inhibitors of MEK and methods of use thereof
App 20050250782 - Marlow, Allison L. ;   et al.
2005-11-10
Heterocyclic inhibitors of MEK and methods of use thereof
App 20050153942 - Wallace, Eli ;   et al.
2005-07-14
Bicyclic inhibitors of MEK and methods of use thereof
App 20050130943 - Wallace, Eli ;   et al.
2005-06-16
Bicyclic inhibitors of MEK and methods of use thereof
App 20050130976 - Wallace, Eli ;   et al.
2005-06-16
Quinazoline analogs as receptor tyrosine kinase inhibitors
App 20050101616 - Wallace, Eli ;   et al.
2005-05-12
Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
App 20050101617 - Wallace, Eli ;   et al.
2005-05-12
Heterocyclic inhibitors of MEK and methods of use thereof
App 20050054701 - Wallace, Eli ;   et al.
2005-03-10
Heterocyclic inhibitors of MEK and methods of use thereof
App 20050049419 - Wallace, Eli ;   et al.
2005-03-03
Quinazoline analogs as receptor tyrosine kinase inhibitors
App 20050043334 - Wallace, Eli ;   et al.
2005-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed